Lianguo Kang

594 total citations
7 papers, 521 citations indexed

About

Lianguo Kang is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lianguo Kang has authored 7 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in Lianguo Kang's work include Estrogen and related hormone effects (3 papers), Renal and related cancers (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Lianguo Kang is often cited by papers focused on Estrogen and related hormone effects (3 papers), Renal and related cancers (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Lianguo Kang collaborates with scholars based in United States, China and Bosnia and Herzegovina. Lianguo Kang's co-authors include Xintian Zhang, Ling Ding, Yan Xie, Yaping Tu, Dong Wang, Zhenming Liu, Zhaoyi Wang, Zoran Gatalica, Semir Vranić and Jun Meng and has published in prestigious journals such as PLoS ONE, Oncogene and Molecular Endocrinology.

In The Last Decade

Lianguo Kang

7 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lianguo Kang United States	6	328	250	207	67	56	7	521
Smitha Yerrum United States	9	246 0.8×	260 1.0×	133 0.6×	50 0.7×	96 1.7×	12	526
A E Hornby United States	7	265 0.8×	304 1.2×	145 0.7×	67 1.0×	62 1.1×	7	540
Edmund C. Chang United States	6	469 1.4×	378 1.5×	218 1.1×	49 0.7×	80 1.4×	6	716
Catherine G.N. Sharma United States	10	233 0.7×	350 1.4×	164 0.8×	44 0.7×	98 1.8×	12	622
Sandrine Bonnet France	12	259 0.8×	434 1.7×	162 0.8×	28 0.4×	91 1.6×	16	585
Shi-Ting Jiang China	4	372 1.1×	240 1.0×	171 0.8×	58 0.9×	73 1.3×	8	462
Murali Venugopalan United States	8	372 1.1×	258 1.0×	147 0.7×	141 2.1×	67 1.2×	8	634
Tze Howe Charn United States	6	299 0.9×	374 1.5×	143 0.7×	28 0.4×	94 1.7×	7	586
V. Craig Jordan United States	9	392 1.2×	156 0.6×	184 0.9×	103 1.5×	121 2.2×	9	502

Countries citing papers authored by Lianguo Kang

Since Specialization

Citations

This map shows the geographic impact of Lianguo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianguo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianguo Kang more than expected).

Fields of papers citing papers by Lianguo Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianguo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianguo Kang. The network helps show where Lianguo Kang may publish in the future.

Co-authorship network of co-authors of Lianguo Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Lianguo Kang. A scholar is included among the top collaborators of Lianguo Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianguo Kang. Lianguo Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Zhang, Xintian, Ling Ding, Lianguo Kang, & Zhaoyi Wang. (2012). Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells. PLoS ONE. 7(1). e30174–e30174. 59 indexed citations

2.

Kang, Lianguo, Yuming Guo, Xintian Zhang, Jun Meng, & Zhaoyi Wang. (2011). A positive cross-regulation of HER2 and ER-α36 controls ALDH1 positive breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 127(3-5). 262–268. 42 indexed citations

3.

Kang, Lianguo, Lei Wang, & Zhaoyi Wang. (2011). Opposite regulation of estrogen receptor-alpha and its variant ER-alpha 36 by the Wilms' tumor suppressor WT1. 1 indexed citations

4.

Kang, Lianguo, Lei Wang, & Zhaoyi Wang. (2011). Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms’ tumor suppressor WT1. Oncology Letters. 2(2). 337–341. 16 indexed citations

5.

Kang, Lianguo, et al.. (2010). A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene. 30(7). 770–780. 138 indexed citations

6.

Kang, Lianguo, Xintian Zhang, Yan Xie, et al.. (2010). Involvement of Estrogen Receptor Variant ER-α36, Not GPR30, in Nongenomic Estrogen Signaling. Molecular Endocrinology. 24(4). 709–721. 208 indexed citations

7.

Kang, Lianguo, et al.. (2009). Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down‐regulation of oestrogen receptor‐α36. Journal of Cellular and Molecular Medicine. 14(6b). 1485–1493. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact